Semi-Annual Consolidated Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7246013

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Semi-annual consolidated statement of income
Statement of income
Ordinary profit (loss)
-1,718,662,000 JPY
-1,426,891,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
73,800,000 JPY
77,149,000 JPY
Taxes and dues
59,074,000 JPY
56,262,000 JPY
Profit (loss) before income taxes
-1,718,662,000 JPY
-1,426,891,000 JPY
Operating profit (loss)
-1,708,224,000 JPY
-1,403,464,000 JPY
Non-operating income
Interest income
337,000 JPY
14,000 JPY
Non-operating income
348,000 JPY
16,000 JPY
Income taxes - current
2,502,000 JPY
2,502,000 JPY
Non-operating expenses
Non-operating expenses
10,787,000 JPY
23,443,000 JPY
Income taxes
2,502,000 JPY
2,502,000 JPY
Profit (loss)
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,721,164,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY
-1,429,393,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.